CLASS II Device recall · Reported 19 Jan 2022 · FDA Enforcement Report

Proteus 235; Version: Pts-8 versions before Pts recalled

Ion Beam Applications is recalling Proteus 235; Version: Pts-8 versions before Pts-8.7.2, distributed in New Jersey, Oklahoma, Tennessee, Virginia. The recall was initiated on 29 Nov 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesPAT.108 (US), PAT.110 (US), PAT.113 (US), PAT.114 (EU), SAT.119 (US).
Quantity recalled5 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0466-2022
FDA event ID
89267
Recalling firm
Ion Beam Applications, Louvain-la-neuve, N/A
Classification
Class II
Status
Terminated
Recall initiated
29 Nov 2021
FDA classified
7 Jan 2022
Reported
19 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Lead & Heavy Metals

Timeline

29 Nov 2021Recall initiated by company
7 Jan 2022Classified by FDA+39 days
19 Jan 2022Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical processes in the environment is not prevented even if some processes of the test environment (tcs) are still running. It may lead to situations where the system is using test processes without notifying the clinical user. If the versions of the processes are different between both environments, this could have an impact on patient treatments.

Lead and other heavy metals accumulate in the body. Children are most at risk; even low levels can affect development.

Product as listed by the FDA

Proteus 235; Version: PTS-8 versions before PTS-8.7.2

Where it was distributed

IN USA: VA, OK, NJ, TN OUS: Czech Republic.

New JerseyOklahomaTennesseeVirginia

Questions about this recall

Is Proteus 235; Version: Pts-8 versions before Pts-8.7.2 recalled?

Yes. Ion Beam Applications recalled Proteus 235; Version: Pts-8 versions before Pts-8.7.2 on 29 Nov 2021. The recall is Class II and its status is Terminated. Recall number Z-0466-2022.

Why was it recalled?

Proton Therapy System (PTS) software can be started in the clinical environment (clinical user) while some processes are still running in the test environment (tcs user). Initiating the startup of the clinical processes in the environment is not prevented even if some processes of the test environment (tcs) are still running. It may lead to situations where the system is using test processes without notifying the clinical user. If the versions of the processes are different between both environments, this could have an impact on patient treatments.

Which lots are affected?

PAT.108 (US), PAT.110 (US), PAT.113 (US), PAT.114 (EU), SAT.119 (US).

Where was it sold?

IN USA: VA, OK, NJ, TN OUS: Czech Republic.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ion Beam Applications

All 36

Other Other Medical Devices recalls

All 13,778